Hematology
Hormone replacement therapy doesn't restore bone mass in thalassemic women
Published in Women's Health Weekly, March 25th, 2004
According to scientists in Italy, "we studied bone mass and metabolism in 30 adult women (age 28.5±1.3) with thalassemia major (TM) and evaluated whether prolonged hormone replacement therapy (HRT) was able to optimize bone accrual."
"TM patients had reduced bone mass, increased bone turnover and lower serum gonadotropin and estradiol levels compared with 10 normal women of similar age. A significant correlation was found between bone mass and sex hormone levels," indicated E. Carmina and colleagues, University of Palermo, Department of Clinical Medicine and Emerging...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Spina Bifida
Reduced folates might be better supplements for expectant mothers - Domestic Violence
One-third of women seeking emergency care have suffered from abuse in lifetime - Geriatrics
Bladder disorder therapy should aim for social continence in those with dementia - Menopause
CASR gene changes may not be markers of postmenopausal osteoporosis - Osteoporosis
Low vitamin B-12 levels associated with bone loss in aging women - Acne
FDA debates more restrictions on Accutane - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
